0000899243-23-016262.txt : 20230622
0000899243-23-016262.hdr.sgml : 20230622
20230622172012
ACCESSION NUMBER: 0000899243-23-016262
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230620
FILED AS OF DATE: 20230622
DATE AS OF CHANGE: 20230622
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: White William Richard
CENTRAL INDEX KEY: 0001778739
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38944
FILM NUMBER: 231034222
MAIL ADDRESS:
STREET 1: C/O AKERO THERAPEUTICS, INC.
STREET 2: 170 HARBOR WAY 2ND FLOOR
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Akero Therapeutics, Inc.
CENTRAL INDEX KEY: 0001744659
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 601 GATEWAY BOULEVARD, SUITE 350
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-487-6488
MAIL ADDRESS:
STREET 1: 601 GATEWAY BOULEVARD, SUITE 350
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-06-20
0
0001744659
Akero Therapeutics, Inc.
AKRO
0001778739
White William Richard
C/O AKERO THERAPEUTICS, INC.
601 GATEWAY BOULEVARD, SUITE 350
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
Chief Financial Officer
0
Common Stock
2023-06-20
4
M
0
17500
7.009
A
39877
D
Common Stock
2023-06-20
4
S
0
20777
55.00
D
19100
D
Stock Option (Right to Buy)
7.009
2023-06-20
4
M
0
17500
0.00
D
2029-04-04
Common Stock
17500
224329
D
The options are vested and currently exercisable..
/s/ Jonathan Young, Attorney-in-Fact
2023-06-22